Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. Mylan applies one global quality standard across our facilities, and across our product line regardless of market. At Mylan, whether it’s a medication for millions or for a handful of people our priorities are to meet or exceed industry standards.

Company Growth (employees)
Hatfield, GB
Size (employees)
35,000 (est)
Mylan was founded in 1961 and is headquartered in Hatfield, GB

Key People at Mylan

Heather Bresch

Heather Bresch

Chief Executive Officer

Mylan Office Locations

Mylan has an office in Hatfield
Hatfield, GB (HQ)
Mosquito Way

Mylan Data and Metrics

Mylan Financial Metrics

Mylan's revenue was reported to be $7.6 b in FY, 2014 which is a 12% increase from the previous period.
$, USD

Revenue (FY, 2014)

7.6 b

Revenue growth (FY, 2013 - FY, 2014), %


Gross profit (FY, 2014)

3.5 b

Gross profit margin (FY, 2014), %


Net income (FY, 2014)

933.1 m

Market capitalization (23-Jun-2017)

20.9 b

Closing share price (23-Jun-2017)


Cash (31-May-2016)

28.7 k
Mylan's current market capitalization is $20.9 b.
$, USDFY, 2013FY, 2014


6.9 b7.6 b

Revenue growth, %


Cost of goods sold

3.9 b4.2 b

Gross profit

3 b3.5 b

Gross profit Margin, %


Operating expense total

1.9 b2.2 b

Interest expense

313.3 m333.2 m

Income tax expense

120.8 m41.4 m

Net Income

626.5 m933.1 m
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


291.3 m28.9 k15.3 k28.7 k

Accounts Receivable

1.8 b9.3 k20 k12.7 k


1.7 b1.7 b

Current Assets

4.5 b38.1 k35.3 k41.4 k


1.7 b858.6 k856.9 k856.3 k


4.3 b210 k189 k189 k

Total Assets

15.2 b1.1 m1.1 m1.1 m

Accounts Payable

1.1 b656.6 k592.6 k639.3 k

Total Debt

8 b6.1 b

Current Liabilities

3 b656.6 k592.6 k639.3 k

Additional Paid-in Capital

4.1 b4.2 b

Retained Earnings

2.7 b

Total Equity

3 b1.9 k2.2 k2.2 k

Debt to Equity Ratio

2.7 x3174607.3 x

Debt to Assets Ratio

0.5 x5478.9 x

Financial Leverage

5.1 x579.4 x492.8 x484.1 x
$, USDFY, 2013FY, 2014

Net Income

626.5 m933.1 m

Depreciation and Amortization

516 m566.6 m

Accounts Receivable

(550 m)(940 m)


(160 m)(150 m)

Accounts Payable

137.2 m(300 k)

Cash From Operating Activities

1.1 b1 b

Capital Expenditures

(334.6 m)(325.3 m)

Cash From Investing Activities

(1.9 b)(800.3 m)

Cash From Financing Activities

692.9 m(267.4 m)

Interest Paid

249.4 m273.8 m

Income Taxes Paid

(1.1 m)78.5 m

Free Cash Flow

1.4 b1.3 b
Y, 2016

Financial Leverage

484.1 x

Mylan Market Value History

Mylan Median Salaries

Source: 123 public H-1B filings from Mylan

Mylan Online and Social Media Presence

Mylan News and Updates

Mylan Company Life and Culture

You may also be interested in